Drug resistant tuberculosis
Tuberculosis multirresistente
Ninguna publicación, nacional o extranjera, podrá reproducir ni traducir sus artículos ni sus resúmenes sin previa autorización escrita del editor; sin embargo los usuarios pueden descargar la información contenida en ella, pero deben darle atribución o reconocimiento de propiedad intelectual, deben usarlo tal como está, sin derivación alguna.
Show authors biography
Tuberculosis is a sickness that in the world has generated 1,4 millions of dead people by year, and today tuberculosis in Latin America is an endemic sikcness despite improvements in treatments and diagnosis methods, else many cases of tuberculosis multi-resistant to the antibiotics of first line are seen these cases show us a big problema of Public Health Service. The treatment of these multi-resistant bacteria need new drugs, drugs called of second line and these drugs are more expensive,have more adverse events and treatments are longer. We have a clinic case of tuberculosis in a woman 25 years old. This patient with resistant treatment to antibiotics of first, many breaths problems; her mother had tuberculosis illness too 4 years ago; her mother received full basic treatment and after criterium of healing.
Article visits 1162 | PDF visits 2818
Downloads
- World Health Organization Global tuberculosis control: WHO report 2012. Geneva: Disponible en:(http://apps.who.int/iris/bitstream/10665/75938/1/9789241564502_eng.pdf)
- Zumla A, Raviglione M, Hafner R, von Reyn F. Current concepts on tuberculosis. N Engl J Med. 2013; 368(8):745-55.
- Frieden TR, Sterling TR, Munsiff SS, Watt CJ, Dye C. Tuberculosis. Lancet 2003;362:887-99.
- Sharma SK, Mohan A. Tuberculosis: From an incurable scourge to a curable disease, ourney over a millennium. Indian J Med Res. 2013;137:455-93.
- Miranda J, Ríos R, Clavijo A, Chacón C, Mattar S. Estudio preliminar de la susceptibilidad antimicrobiana y variabilidad genética de Mycobacterium tuberculosis en un área del Caribe colombiano. Colomb Med. 2006;37:275-86.
- Maguire H, et al. Molecular epidemiology of tuberculosis in London 1995–7 showing low rate of active transmission. J Clin Pathol. 2003;56(2)121-6.
- Edli BR, et al. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med. 1992;326:1514-21.
- Field SK, et al. New treatment options for multidrug-resistant tuberculosis. Ther Adv Respir Dis. 2012;6(5):255-68.
- Zumla A, et al. Drug resistant tuberculosis current dilemmas, unanswered questions, challenges, and priority needs. J Infect Dis. 2012;205(2):228-40.
- Dooley KE, et al. Old drugs, new purpose: retooling existing drugs for optimized treatment of resistant tuberculosis. Clin Infect Dis. 2012;55(4):572-81.
- Lienhardt C, et al. New drugs for the treatment of tuberculosis: needs, challenges, promise, and prospects for the future. J Infect Dis. 2012;205(2):241-9.
- Vashakidze S, et al. Favorable outcomes for multidrug and extensively drug resistant tuberculosis patients undergoing surgery. Ann Thorac Surg. 2013;95(6):1892-8.
- Kempker RR, Vashakidze S, Solomonia N, Dzidzikashvili N, Blumberg HM. Surgical treatment of drug-resistant tuberculosis. Lancet Infect Dis. 2012;12(2):157-66.
Information
Journal history
Keywords
QR code
Funding
Directories and indexes
